This session will provide an overview of the US life sciences landscape, including FDA regulation, reimbursement and market access considerations, partnerships, investment opportunities and routes to market.
What you’ll learn
Understand the key drivers of demand and growth opportunities for UK life sciences companies in the US market.
Identify the regulatory, clinical and market access considerations that can influence successful commercialization in the United States.
Learn how to develop an effective US market entry strategy, including partnerships, customers, investors and support available through BIST.
Description
The United States is home to more than 340 million people and is the world’s largest healthcare market, with annual healthcare spending exceeding $5 trillion. It is also the global leader in life sciences investment, research and commercialization, with many of the world’s largest pharmaceutical, biotechnology, medical technology and healthcare companies based in the US.
The session will provide an overview of the US life sciences landscape, covering key areas such as FDA regulation, reimbursement and market access considerations, partnerships, investment opportunities and routes to market. Attendees will hear practical advice on what companies should think about before entering the US and where BIST can help connect businesses with customers, partners, investors and wider networks across North America.
The webinar will also explore some of the common challenges UK companies face when expanding into the US, including navigating a complex healthcare ecosystem, understanding evidence requirements, identifying the right commercial partners and building an effective market entry strategy. Participants will gain insight into key innovation hubs and opportunities across biotechnology, pharmaceuticals, diagnostics, medical technology and digital health.
